MEGAKARYON CORPORATION
Megakaryon Corporation is a medical Research Company.
MEGAKARYON CORPORATION
Industry:
Health Care Medical Nursing And Residential Care Product Research
Founded:
2011-09-01
Address:
Kyoto, Kyoto, Japan
Country:
Japan
Website Url:
http://www.megakaryon.com
Total Employee:
1+
Status:
Active
Total Funding:
10.2 B JPY
Technology used in webpage:
SPF Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Nginx Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS SAKURA Internet
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Crowd Sales
Crowd Sales is a medical company
Nanotheta
Nanotheta is a health care company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Sanryokai Medical Corporation
Sanryokai Medical Corporation provides general medical and surgical hospital services.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovation Network Corporation of Japan
Innovation Network Corporation of Japan investment in Series D - Megakaryon Corporation
Sekisui Chemical Company
Sekisui Chemical Company investment in Series D - Megakaryon Corporation
Satake Chemical Machinery
Satake Chemical Machinery investment in Series D - Megakaryon Corporation
SBI Investment
SBI Investment investment in Series D - Megakaryon Corporation
Kyoto Seisakusho
Kyoto Seisakusho investment in Series C - Megakaryon Corporation
Japan Asia Investment
Japan Asia Investment investment in Series C - Megakaryon Corporation
Miyako Capital
Miyako Capital investment in Series C - Megakaryon Corporation
Nissay Capital
Nissay Capital investment in Series C - Megakaryon Corporation
Mizuho Capital
Mizuho Capital investment in Series C - Megakaryon Corporation
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series C - Megakaryon Corporation
Official Site Inspections
http://www.megakaryon.com
- Host name: www1055.sakura.ne.jp
- IP address: 219.94.129.65
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "Megakaryon Corporation"
Megakaryon Corporation
Oct 27, 2021 · Megakaryon Corporation has become a consolidated subsidiary of Sysmex Corporation. Megakaryon Corporation initiates first-in-human clinical trial of allogenic human iPSC-derived HLA homozygous platelets (MEG-002).See details»
About Megakaryon - Megakaryon Corporation
By utilizing the regenerative potential of induced pluripotent stem (iPS) cells, we aim to produce high-quality platelets and other blood products that are safe, with reliable supply on demand …See details»
Company Objectives - Megakaryon Corporation
Megakaryon Corporation was founded to employ the application of iPS cells in platelet production, thereby establishing techniques to manufacture safe and low-cost platelets which can be produced on demand.See details»
Megakaryon Corporation | INCJ, Ltd.
Aug 26, 2013 · In the field of regenerative medicine using iPS Cell, where Japan is at the forefront, Megakaryon is the leading start-up closest to world-wide commercialization; …See details»
Megakaryon Corporation | Innovation Network Corporation of Japan
Aug 26, 2013 · In the field of regenerative medicine using iPS Cell, where Japan is at the forefront, Megakaryon is the leading start-up closest to world-wide commercialization; …See details»
Sysmex Makes Megakaryon Corporation into a Subsidiary, Aiming …
Dec 21, 2023 · Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces that on December 20, 2023, it acquired additional shares in Megakaryon Corporation (HQ: …See details»
Megakaryon Corporation - J-Startup
In cooperation with domestic and foreign academic research institutions and companies, Megakaryon will establish techniques to manufacture safe and low-cost platelet products constantly without relying on blood donations, achieve a …See details»
Megakaryon: Why Japan Is Betting Big On A Stem Cell …
Mar 5, 2018 · Megakaryon is a unique company in that it’s the brainchild of two universities with the government as the main shareholder. It’s also symbolic of the new innovation-focused ecosystem taking root...See details»
Megakaryon Corporation - Venture Valuation
Megakaryon is internationally the first and only company that owns proprietary technology to manufacture large quantities of iPS cell-originated platelets. Our technology was invented by …See details»
Interviews with leading Life Sciences companies: Megakaryon
Aug 26, 2024 · Megakaryon is aiming for mass production of the first global iPSC (induced Pluripotent Stem Cell)-derived platelet product for allogeneic use. Learn more about the Kyoto …See details»
Megakaryon Corporation Becomes a Consolidated Subsidiary of …
Dec 21, 2023 · As a member of the Sysmex Group, Megakaryon will continue to the early pursue commercialization of human iPS cell-derived platelet products. For further information, please …See details»
MEGAKARYON CORPORATION - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MEGAKARYON CORPORATION of KYOTO, KYOTO. Get the latest business insights from …See details»
MEGAKARYON CORPORATION Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MEGAKARYON CORPORATION of KYOTO, KYOTO. Get the latest business insights from …See details»
Publicity materials - Megakaryon Corporation
Megakaryon Corporation initiates first-in-human clinical trial of allogenic human iPSC-derived HLA homozygous platelets (MEG-002). Megakaryon Corporation announces the completion of 30 …See details»
Megakaryon - Overview, News & Similar companies | ZoomInfo.com
View Megakaryon (www.megakaryon.com) location in Kyoto, Japan , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Megakaryon Company Profile 2024: Valuation, Investors
Developer of blood cell production technology designed to promote the application of platelet techniques to clinical use. The company's technology specializes in creating transfusion …See details»
Interviews with leading Life Sciences companies: Megakaryon …
Mar 5, 2018 · Megakaryon will change the transfusion practices by supplying safe and cost-saving platelets produced in vitro. Mass production in Japan is expected to begin in 2020. Venture …See details»
MEG-002: Exploratory clinical study in thrombocytopenic patients
Aug 19, 2021 · A non-nucleated disk-shaped cell formed by extrusion from megakaryocytes, found in the blood of all mammals, and mainly involved in blood coagulation.;See details»
Core Technologies - Megakaryon Corporation
Our technology aims to collect the iPS cells from donors with rare HLA types and use these cells to prepare megakaryocytes that can then be stored frozen in a cell bank and propagated in …See details»
Pipeline&Partnership - Megakaryon Corporation
In addition to platelet products derived from iPS cells for regenerative medicine and blood transfusions, Megakaryon has developed a pipeline utilizing the iMDF ® (iPS-Megakaryocyte …See details»